Firan Technology Group is undervalued, says Paradigm Capital

Following the company’s annual general meeting, Paradigm Capital analyst Daniel Kim is feeling bullish about Firan Technology Group (Firan Technology Stock Quote, Chart, News: TSX:FTG).

In a research update to clients today, Kim maintained his “Buy” rating and one-year price target of $5.75 on Firan Technology Group, implying a return of 38 per cent at the time of publication, including dividend.

Kim says despite the fact that he has had numerous upward revisions to his forecasts, he continues to see a company in Firan whose margins are “on the tipping point” of a major inflection that should drive another material uptick in revenue and margins.

“Recent acquisitions (with more to come) and new programs promise to deliver terrific growth, both top line and importantly, bottom line leverage, with 30% EBITDA contribution from acquired assets,” the analyst says. “Emerging still are new programs, new products, growing cross selling opportunities and a potentially massive increase in utilization in the company’s China JV.”

Kim thinks Firan will generate Adjusted EBITDA of $13.5-million on revenue of $105.7-million in fiscal 2017. He expects those numbers will improve to EBITDA of $19.4-million on a topline of $117.8-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ftg
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

3 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

1 day ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

1 day ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

1 day ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago